Photo of Nicholas A. Dorsey

Nicholas A. Dorsey

Partner, Cravath

212-474-1764ndorsey@cravath.com

Two Manhattan West
375 Ninth Avenue
New York, NY 10001

View Firm Biography

Nicholas A. Dorsey focuses his practice on representing corporate issuers and borrowers, and financial institutions, lenders and other parties, in public and private offerings of securities, loan transactions and other financing transactions. He also represents companies in mergers and acquisitions and regularly advises clients in connection with public disclosure and corporate matters. He is Co-Head of the Venture Capital & Growth Equity Practice, where he dedicates significant time to providing commercial and strategic advice to startup, early‑stage and founder‑led companies and investors in such companies. Dorsey advises clients in connection with matters involving artificial intelligence and other emerging technologies. Clients regularly seek his counsel for the practical, commercial advice he offers with respect to their most challenging matters.

In addition to traditional capital markets offerings and banking transactions, Dorsey’s financing practice includes advising on liability management transactions, asset- and royalty-based financings and securitizations. He has extensive cross‑border experience and counts multiple international companies and financial institutions among his diverse client base.

Lawdragon Honors

Honor Year Practice
The 2026 Lawdragon 500 Leading Dealmakers in America 2026 Corporate Finance, Securities
The 2025 Lawdragon 500 Leading Dealmakers in America 2025 Corporate Finance, Securities

Notable work highlights include:

  • IPOs, direct listings, SPAC combinations and spin-offs for companies such as Alliance Laundry Systems, Alliant Techsystems (ATK), Cano Health, Climate Transition Capital Acquisition I, Corteva, Costamare, DRI Healthcare Trust, On, Palantir, SciPlay, Swvl, Vaxxinity, Vista Outdoor and Younited
  • Public and private equity financings for companies such as Akorn, Beacon Roofing Supply, Blue Current, Credit Suisse, DRI Healthcare Trust, Forterra, Hewlett Packard Enterprise, Oddity, Orcosa, PG&E, PNC, Replimune and Swvl 
  • Investor representations such as DMGT in the $8.1 billion business combination of Cazoo and AJAX I SPAC; Prosus in its $500 million PIPE investment in connection with Churchill II SPAC’s $1.5 billion merger with Skillsoft and acquisition of Global Knowledge; Richemont in its $1.1 billion PIPE investment in Farfetch, in partnership with Alibaba; Shaolin Capital Management in its $50 million PIPE investment in connection with the business combination of Bitcoin Depot and GSR II Meteora Acquisition Corp.; Oxford Properties in the $5.1 billion IPO of Lineage; DRI Capital and its affiliates in multiple matters, including equity investments and acquisitions of traditional and synthetic royalty interests; and a variety of venture capital firms, corporate venture capital departments and angel investors in investments of all sizes
  • Debt offerings for companies such as Beacon Roofing Supply, CBRE, Chemours, Corteva, Credit Acceptance, Credit Suisse, Disney, Expedia, Graham Holdings, Hewlett Packard Enterprise, HP, Lazard, Navistar, Nestlé, Occidental Petroleum, Oddity, Outbrain, Parker‑Hannifin, PG&E and Sherwin‑Williams
  • Banking and credit transactions for companies such as Bay Club, Beacon Roofing Supply, Centene, The Collective, Outbrain, PG&E, RedHill Biopharma and WiLine Networks
  • Accounts-receivable financings, securitizations and other structured financings for companies such as Albemarle, Amentum, Citibank Credit Card Issuance Trust, Corteva, Crown Castle, Drug Royalty, Ferroglobe, INEOS, Martin Marietta, Mylan, Occidental Petroleum, Olin, RedHill Biopharma, US Foods and Viatris
  • PG&E’s tri‑tranche offering, which represents the largest utility public equity offering in history, as well as the arrangement of its Debtor‑in‑Possession (“DIP”) financing and other advisory matters relating to its chapter 11 proceedings